학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 3건 | 목록 1~20
Academic Journal
Godman B; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.; Health Economics Centre, University of Liverpool Management School, Liverpool, United Kingdom.; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.; School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; Bucsics A; Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA), Brussels, Belgium.; Vella Bonanno P; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.; Oortwijn W; Ecorys, Rotterdam, Netherlands.; Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands.; Rothe CC; Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.; Ferrario A; Division of Health Policy and Insurance Research, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States.; Bosselli S; EURORDIS-Rare Diseases Europe, Paris, France.; Hill A; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.; Martin AP; Health Economics Centre, University of Liverpool Management School, Liverpool, United Kingdom.; HCD Economics, The Innovation Centre, Daresbury, United Kingdom.; Simoens S; KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.; Kurdi A; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq.; Gad M; Global Health and Development Group, Imperial College, London, United Kingdom.; Gulbinovič J; Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.; Timoney A; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.; NHS Lothian, Edinburgh, United Kingdom.; Bochenek T; Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.; Salem A; IQVIA, Brussels, Belgium.; Hoxha I; Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania.; Sauermann R; Hauptverband der Österreichischen Sozialversicherungsträger, Vienna, Austria.; Massele A; Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana.; Guerra AA Jr; Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Av. Presidente Antônio Carlos, Belo Horizonte, Brazil.; SUS Collaborating Centre - Technology Assessment & Excellence in Health (CCATES/UFMG), College of Pharmacy, Federal University of Minas Gerais. Av. Presidente Antônio Carlos, Belo Horizonte, Brazil.; Petrova G; Department of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; Mitkova Z; Department of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; Achniotou G; Health Insurance Organisation (HIO), Nicosia, Cyprus.; Laius O; State Agency of Medicines, Tartu, Estonia.; Sermet C; IRDES, Paris, France.; Selke G; Wissenschaftliches Institut der AOK (WIdO), Berlin, Germany.; Kourafalos V; EOPYY-National Organization for the Provision of Healthcare Services, Athens, Greece.; Yfantopoulos J; School of Economics and Political Science, University of Athens, Athens, Greece.; Magnusson E; Department of Health Services, Ministry of Health, Reykjavík, Iceland.; Joppi R; Pharmaceutical Drug Department, Azienda Sanitaria Locale of Verona, Verona, Italy.; Oluka M; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi, Kenya.; Kwon HY; Division of Biology and Public Health, Mokwon University, Daejeon, South Korea.; Jakupi A; UBT - Higher Education Institute, Prishtina, Kosovo.; Kalemeera F; Department of Pharmacology and Therapeutics, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.; Fadare JO; Department of Pharmacology and Therapeutics, Ekiti State University, Ado-Ekiti, Nigeria.; Melien O; Norwegian Institute of Public Health, Oslo, Norway.; Pomorski M; Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw, Poland.; Wladysiuk M; HTA Consulting, Cracow, Poland.; Marković-Peković V; Ministry of Health and Social Welfare, Banja Luka, Bosnia and Herzegovina.; Department of Social Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.; Mardare I; Public Health and Management Department, Faculty of Medicine, 'Carol Davila', University of Medicine and Pharmacy Bucharest, Bucharest, Romania.; Meshkov D; National Research Institution for Public Health, Moscow, Russia.; Novakovic T; ZEM Solutions, Belgrade, Serbia.; Fürst J; Health Insurance Institute, Ljubljana, Slovenia.; Tomek D; Faculty of Medicine, Slovak Medical University in Bratislava, Bratislava, Slovakia.; Zara C; Drug Territorial Action Unit, Catalan Health Service, Barcelona, Spain.; Diogene E; Vall d'Hebron University Hospital, Fundació Institut Català de Farmacologia, Barcelona, Spain.; Meyer JC; School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; Malmström R; Department of Medicine Solna, Karolinska Institutet and Clinical Pharmacology Karolinska University Hospital, Stockholm, Sweden.; Wettermark B; Department of Medicine Solna, Karolinska Institutet and Clinical Pharmacology Karolinska University Hospital, Stockholm, Sweden.; Department of Healthcare Development, Stockholm County Council, Stockholm, Sweden.; Matsebula Z; Raleigh Fitkin Memorial Hospital, Manzini, Swaziland.; Campbell S; Division of Population Health, Health Services Research and Primary Care, Centre for Primary Care, University of Manchester, Manchester, United Kingdom.; NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, United Kingdom.; Haycox A; Health Economics Centre, University of Liverpool Management School, Liverpool, United Kingdom.
Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Print ISSN: 2296-2565 (Print) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Achniotou, G.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어